Literature DB >> 8210368

Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen.

L H Schwartz1, S E Seltzer, C M Tempany, S G Silverman, D R Piwnica-Worms, D F Adams, L Herman, L T Herman, R Hooshmand.   

Abstract

PURPOSE: To evaluate use of fast spin-echo (FSE) magnetic resonance imaging with and without fat suppression in the liver and upper abdomen.
MATERIALS AND METHODS: Conventional spin-echo (SE) T2-weighted, FSE T2-weighted, and fat-suppressed FSE T2-weighted images from 37 patients strongly suspected to have focal hepatic lesions were evaluated.
RESULTS: Quantitative analysis demonstrated that fat-suppressed FSE imaging had the highest lesion-liver contrast-to-noise ratio; conventional SE imaging, the lowest. In a qualitative analysis, FSE imaging was preferred. In a rank order analysis, FSE imaging was preferred 83% of the time and fat-suppressed FSE imaging 17% of the time as regards overall image quality; fat-suppressed FSE imaging was preferred 64% of the time, FSE imaging 23% of the time, and conventional SE imaging 13% of the time as regards signal abnormality detection.
CONCLUSION: FSE imaging with and without fat suppression is a potentially useful pulse sequence for evaluating the upper abdomen.

Entities:  

Mesh:

Year:  1993        PMID: 8210368     DOI: 10.1148/radiology.189.2.8210368

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Magnetic resonance cholangiography.

Authors:  D M Schuster; M C Pedrosa; A H Robbins
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

2.  Accelerated single-shot T2-weighted fat-suppressed (FS) MRI of the liver with deep learning-based image reconstruction: qualitative and quantitative comparison of image quality with conventional T2-weighted FS sequence.

Authors:  Krishna Shanbhogue; Angela Tong; Paul Smereka; Dominik Nickel; Simon Arberet; Rebecca Anthopolos; Hersh Chandarana
Journal:  Eur Radiol       Date:  2021-05-07       Impact factor: 5.315

Review 3.  Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions.

Authors:  Andrea Agostini; Moritz F Kircher; Richard K G Do; Alessandra Borgheresi; Serena Monti; Andrea Giovagnoni; Lorenzo Mannelli
Journal:  Semin Roentgenol       Date:  2016-05-30       Impact factor: 0.800

4.  Whole-body MRI for metastatic cancer detection using T2 -weighted imaging with fat and fluid suppression.

Authors:  Xinzeng Wang; Ali Pirasteh; James Brugarolas; Neil M Rofsky; Robert E Lenkinski; Ivan Pedrosa; Ananth J Madhuranthakam
Journal:  Magn Reson Med       Date:  2018-02-14       Impact factor: 4.668

5.  Four dimensional magnetic resonance imaging with retrospective k-space reordering: a feasibility study.

Authors:  Yilin Liu; Fang-Fang Yin; Nan-kuei Chen; Mei-Lan Chu; Jing Cai
Journal:  Med Phys       Date:  2015-02       Impact factor: 4.071

6.  Detection of focal hepatic lesions with 3-T MRI: comparison of two-dimensional and three-dimensional T2-weighted sequences.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Kimihiro Kajita; Hiroshi Kawada; Yoshifumi Noda; Noriyuki Moriyama
Journal:  Jpn J Radiol       Date:  2012-08-22       Impact factor: 2.374

7.  Liver MR imaging: comparison of respiratory triggered fast spin echo with T2-weighted spin-echo and inversion recovery.

Authors:  M T Keogan; C E Spritzer; E K Paulson; S S Paine; L Harris; J L Dahlke; J R MacFall
Journal:  Abdom Imaging       Date:  1996 Sep-Oct

8.  Two-point Dixon technique provides robust fat suppression for multi-mouse imaging.

Authors:  Dustin K Ragan; James A Bankson
Journal:  J Magn Reson Imaging       Date:  2010-02       Impact factor: 4.813

Review 9.  Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance.

Authors:  Hyo Jung Park; Nieun Seo; So Yeon Kim
Journal:  Korean J Radiol       Date:  2022-04-13       Impact factor: 7.109

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.